Avner Schlessinger

Avner Schlessinger, PhD

  • ASSISTANT PROFESSOR | Pharmacological Sciences

Research Topics:

Cancer, Computational Biology, Drug Design and Discovery, Membrane Proteins/Channels, Protein Structure/Function, Transporters

Dr. Schlessinger is an Assistant Professor in the Department of Pharmacology and Systems Therapeutics, and is a member of the Tisch Cancer Institute, at the Icahn School of Medicine at Mount Sinai in New York City. The overall goal of Dr. Schlessinger’s lab is to improve and automate the structure-based discovery process by developing and applying novel computational approaches, and to collaborate with experimental labs to characterize pharmacologically important proteins, with a long-term goal of developing cancer drugs. His lab publishes in the areas of structural biology, bioinformatics, and drug discovery, as well as in personalized medicine and pharmacogenetics. Dr. Schlessinger graduated from Tel Aviv University with a B.Sc. in Chemistry and Biology, and completed his Ph.D. from Columbia University in the Department of Biochemistry and Molecular Biophysics. Following his graduate studies, Dr. Schlessinger was an NIH NRSA postdoctoral fellow at the Department of Bioengineering and Therapeutic Sciences, University of California San Francisco (UCSF), where he developed methods for protein structure prediction and structure-based drug design. Dr. Schlessinger is an Associate Editor of PLOS Computational Biology. Dr. Schlessinger joined the faculty at the Icahn School of Medicine at Mount Sinai in January, 2013.

Multi-Disciplinary Training Areas

Biophysics and Systems Pharmacology [BSP], Cancer Biology [CAB]

Education

BSc, Tel Aviv University

PhD, Columbia University

Postdoctoral Training, University of California, San Francisco